» Authors » Ourania Papaioannou

Ourania Papaioannou

Explore the profile of Ourania Papaioannou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 188
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kotsiou O, Kirgou P, Tzouvelekis A, Kolilekas L, Manali E, Papiris S, et al.
Sarcoidosis Vasc Diffuse Lung Dis . 2024 Dec; 41(4):e2024055. PMID: 39655591
Background And Aim: There is limited data on the prevalence of SARS-COV-2 in sarcoidosis patients and the underlying parameters linked to severity. We aimed to conduct a national multicenter study...
2.
Moulias A, Koros R, Papageorgiou A, Katechis S, Patrinos P, Trigka-Vasilakopoulou A, et al.
Life (Basel) . 2024 Nov; 14(11). PMID: 39598310
There is increasing evidence that COVID-19 induces endothelial dysfunction that may precede thrombotic and cardiovascular complications. The aim of this study is to evaluate endothelial function using peripheral arterial tonometry...
3.
Papaioannou O, Koulousousa E, Karampitsakos T, Tzouvelekis A
Cureus . 2023 Dec; 15(11):e48330. PMID: 38060701
A 60-year-old man was referred to our Respiratory Department with progressive dyspnea on exertion and productive cough over the past two months. High-resolution computed tomography showed diffuse ground glass opacities...
4.
Karampitsakos T, Galaris A, Chrysikos S, Papaioannou O, Vamvakaris I, Barbayianni I, et al.
Respir Res . 2023 Nov; 24(1):279. PMID: 37964265
Background: Mediastinal lymph node enlargement is prevalent in patients with idiopathic pulmonary fibrosis (IPF). Studies investigating whether this phenomenon reflects specific immunologic activation are lacking. Methods: Programmed cell death-1 (PD-1)/...
5.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou V, Papanikolaou I, et al.
Front Med (Lausanne) . 2023 May; 10:1194925. PMID: 37122328
[This corrects the article DOI: 10.3389/fmed.2022.1083264.].
6.
Bartziokas K, Papathanasiou E, Papaioannou A, Papanikolaou I, Antonakis E, Makou I, et al.
J Pers Med . 2023 Apr; 13(4). PMID: 37109072
Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During...
7.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou V, Papanikolaou I, et al.
Front Med (Lausanne) . 2023 Feb; 9:1083264. PMID: 36733935
Introduction: Post-acute sequelae of COVID-19 seem to be an emerging global crisis. Machine learning radiographic models have great potential for meticulous evaluation of post-COVID-19 interstitial lung disease (ILD). Methods: In...
8.
Karampitsakos T, Tzilas V, Papaioannou O, Chrysikos S, Vasarmidi E, Juge P, et al.
Front Med (Lausanne) . 2023 Jan; 9:1096203. PMID: 36698813
Introduction: Myositis associated interstitial lung disease (ILD) seems to be an under-recognized entity. Methods: In this multicenter, retrospective study, we recorded between 9/12/2019 and 30/9/2021 consecutive patients who presented in...
9.
Karampitsakos T, Papaioannou O, Tsiri P, Katsaras M, Katsimpris A, Kalogeropoulos A, et al.
Clin Microbiol Infect . 2022 Oct; 29(3):372-378. PMID: 36273769
Objective: Randomized controlled trials comparing tocilizumab and baricitinib in patients with coronavirus disease 2019 (COVID-19) are needed. This was an open-label, randomized controlled trial aiming to address this unmet need....
10.
Chrysikos S, Papaioannou O, Karampitsakos T, Tavernaraki K, Thanou I, Filippousis P, et al.
Adv Respir Med . 2022 Aug; 90(4):300-309. PMID: 36004959
Background: Diagnostic work-up of pulmonary embolism (PE) remains a challenge. Methods: We retrospectively studied all patients referred for computed tomography pulmonary angiography (CTPA) with suspicion of PE during a 12-month...